Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Sajdak S, Moszynski R, Opala T
Eur J Gynaecol Oncol 2002;23(4):325-326.
NATA Rating :
Review by :
This is a case report of two female patients with severe vaginal bleeding following previous treatment of gynecological malignancies and no pre-existing coagulation factor deficiency. Bleeding was controlled with two and one relatively small doses of rFVIIa, respectively.
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.